Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22648957 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder
Interventions: Drug: 8IU intranasal oxytocin;   Drug: 24IU intranasal oxytocin;   Drug: Placebo;   Device: OptiNose Breath Powered Bi
2 Completed Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults
Condition: Healthy Male Adults
Interventions: Drug: 8IU intranasal oxytocin;   Drug: 24 IU intranasal oxytocin;   Drug: 1 IU intravenous oxytocin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.